Skip to main content
Caplight Logo









MYNERVA AG

MYNERVA AG

Private
ZurichHealthcare & Life Scienceshttps://www.mynerva.com/

Last Round

Grant

Oct 31, 2025

Total Funding Raised

$5.96M

Company Overview

MYNERVA AG is a medical device company that develops wearable neuro-robotic technology to reduce chronic pain and restore the sense of touch in patients with diabetic peripheral neuropathy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuroprostheticdiabetic peripheral neuropathyDPNsmart sockwearable medical devicesensory restorationpain managementelectrical stimulationmedtechhealth IoTfall preventionbioelectronic medicinedigital healthneuromodulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MYNERVA AG Comparables

Compare MYNERVA AG with similar companies based on industry and business-model similarity.

MYNERVA AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Walk With Path
81%
RxFunction
79%
SensArs Neuroprosthetics
72%

MYNERVA AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 31, 2025
GrantJun 23, 2025
SeedSep 1, 2024
GrantNov 24, 2023
GrantSep 26, 2023

Key People

Founding team and executive leadership

Greta Preatoni

Chief Executive Officer

Executive Team

Luigi Carotenuto

Chief Technology Officer

Executive Team

MYNERVA AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 9, 2026

    Grew 33% QoQ from 12 to 16 employees.

  • Dec 23, 2025

    Grew 30% QoQ from 10 to 13 employees.

MYNERVA AG Filings

Explore SEC and related filing metadata, where available.

MYNERVA AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MYNERVA AG's valuation, stock price, and market status.

Is MYNERVA AG a public or private company?

MYNERVA AG is a private company.

What is the current stock price of MYNERVA AG?

MYNERVA AG is a private company with no public stock price. No recent secondary market data is available.

How much is MYNERVA AG worth (valuation)?

Valuation information for MYNERVA AG is not publicly available.

Can I buy MYNERVA AG stock?

MYNERVA AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MYNERVA AG's last funding round?

MYNERVA AG's most recent funding round was Grant on October 31, 2025.

Who are the main investors in MYNERVA AG?

Key investors in MYNERVA AG include Diabetes Center Berne, MassChallenge Switzerland, Future of Health Grant, >>venture>> Foundation.

Will MYNERVA AG IPO soon?

No public IPO plans have been announced for MYNERVA AG.

How can I track MYNERVA AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MYNERVA AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range16
Year Founded2025
Last FundingOct 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?